Refreshing results…
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
UploadA selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
UploadMissing publications? Search for publications with a matching author name.